Are you planning to attend the BIO Korea 2025 event in Coex, Seoul May 7 – 9, 2025?
If so, try to catch up with the Abzena team on-site Rob Holgate and Eun Park

Abzena is the leading bioconjugate & biologics CDMO+CRO, providing fully integrated, tailored drug design, development & GMP manufacturing services spanning from discovery through commercial for global biotech and pharma customers. Whether you need support with an ADC, AOC or RDC, our drug development experts can guide you towards a faster path to clinical and commercial success.

We are ready to discuss how we can help de-risk and streamline your program with innovative solutions like AbZelectPRO™ – high-yielding cell line development, or ThioBridge™ – site specific conjugation technology, that can improve your oncology program’s chances of success.

Schedule a meeting with our experts at Bio Korea to learn how we can rapidly move your program forward to its next milestone – with greater success!